Corrigendum to Ng MS, Malacova E, Hurst C, David MC, Johnson DW, Mallett AJ. “Clinical Outcomes of People With Fabry Disease — ANZDATA Registry Study.” Kidney Int Rep. 2021;6:2481–2485

• Monica S. Ng,
• Eva Malacova,
• Cameron Hurst,
• Michael C. David,
• David W. Johnson,
• Andrew J. Mallett

Affiliations

Monica S. Ng

Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia; Kidney Health Service, Royal Brisbane and Women’s Hospital, Butterfield Street, Herston, Queensland, Australia; Faculty of Medicine and Institute for Molecular Biosciences, The University of Queensland, Brisbane, Australia

Eva Malacova

QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia; Faculty of Health, QUT, Brisbane, Queensland, Australia; School of Global and Population Health, University of Western Australia, Perth, WA, Australia

Cameron Hurst

QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia

Michael C. David

School of Medicine and Dentistry, Griffith University, Gold Coast, Queensland, Australia

David W. Johnson

Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia; Centre for Kidney Disease Research, University of Queensland, Brisbane, Australia; Translational Research Institute, Brisbane, Australia

Andrew J. Mallett

Faculty of Medicine and Institute for Molecular Biosciences, The University of Queensland, Brisbane, Australia; Department of Renal Medicine, Townsville University Hospital, Townsville, Queensland, Australia; College of Medicine and Dentistry, James Cook University, Townsville, Queensland, Australia